Presentations by Deciphera

For more information or copies of Deciphera presentations, contact us at 785.830.2100 or info@deciphera.com.

  • 04.2011

    “FMS Kinase Inhibitor DCC-2909 for Treatment of Human Malignancies.” AACR, Orlando, FL 2011.

  • 03.2011

    “Durable Type II Inhibitors that Bind to Kinase Residues Involved in Conformational Fluxing.” Protein Kinases Congress, Berlin, Germany 2011.

  • 01.2011

    “Kinase Inhibitor Platform, High Level Pipeline Summaries and Partnering Opportunities.” Biotech Showcase, San Francisco, CA 2011.

  • 04.2010

    “Narrow Spectrum Inhibitors of cFMS, cKIT and PDGFR Kinases as Therapies for Rheumatoid Arthritis and other Autoimmune Diseases.” CHI Drug Discovery Chemistry, San Diego, CA 2010.

  • 04.2010

    “Small Molecule Modulators of MET Kinase for Treatment of Human Malignancies.” AACR, Washington, DC 2010.

  • 11.2009

    “Oncology Opportunities with Deciphera Development Candidates: DCC-2036 Phase 1 Drug Candidate.” CHI Kinase, Boston, MA 2009.

  • 04.2009

    “Small Molecule Modulators of KIT Kinase for Treatment of Gastrointestinal Stromal Tumors (GIST Inhibitors of Juxtamembrane Domain, D816V, T670I and V654A Mutant Forms.” AACR, Denver, CO 2009.